Skip to main content
Clinical Trials/TCTR20230418007
TCTR20230418007
Unknown
Phase 4

A pilot study of efficacy and safety of microneedling-assisted topical botulinum toxin A for the treatment of enlarged facial pores: a split-face randomized-controlled pilot study

Faculty of Medicine Siriraj Hospital, Mahidol University0 sites25 target enrollmentApril 18, 2023

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Enlarged facial pores
Sponsor
Faculty of Medicine Siriraj Hospital, Mahidol University
Enrollment
25
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 18, 2023
End Date
May 31, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Thai descendants
  • 2\. There are enlarged pores on both cheeks. By definition, enlarged pores must be visible to the naked eye (visible topographic enlarged facial pores) at a distance of 30 cm and examined by two dermatologists with a consensus.

Exclusion Criteria

  • 1\. Pregnant, breastfeeding, or after giving birth for no more than three months or plan to become pregnant during six months.
  • 2\. Using vitamin A compounds or chemical peeling agents or injecting botulinum toxin on the cheek area in the last six months
  • 3\. History of allergy to anesthetics or botulinum toxin
  • 4\. History of hypertrophic scars or keloids
  • 5\. Open wounds, infected skin, or skin rashes on the face
  • 6\. Having underlying diseases such as diabetes, collagen\-related disorders, immunodeficiencies, or having an underlying condition that the researcher considers to be unsafe if participating in the program, such as epilepsy
  • 7\. History of regularly using steroids or smoking.
  • 8\. History of using anticoagulants, antiplatelet agents, or ginkgo leaf extract.
  • 9\. Volunteers with an implanted pacemaker with an implanted metallic device.

Outcomes

Primary Outcomes

Not specified

Similar Trials